Co-Dergocrine Mesylate
Overview
Co-Dergocrine Mesylate is used to treat symptoms of mild to moderate dementia in elderly. In some countries , it has been used in the treatment of hypertension, migrain, and in peripheral vascular disease.
Categories
- 24 Psychotherapeutic drugs
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Xylometazoline (HCl)'s dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 0.3 mg | 0.3 (0.3) | 12 hourly | IM | For one week. Followed by oral therapy |
| 1.5 to 2 mg | 1.8 (1.75) | 8 hourly | PO | For atleast 3 months (For Once a day dosage 4.5mg before breakfast) |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Xylometazoline (HCl) is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Xylometazoline (HCl) is available. |
High Risk Groups
Back to top
Warning / Precautions
Co-Dergocrine Mesylate should be used with caution in patients with severe bradycardia. Blood pressure should be checked following parentral administration as a drop in blood pressure may occur. It is classified as pregnancy category C and should be used during prgnancy only if clearly needed.
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Xylometazoline (HCl)
Back to top
Manufacturers of
Co-Dergocrine Mesylate
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic